Z. Guan

发表

[Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].

Y. Huang, Zhi-xiang Shen, Hong-Yu Zhang, 2005, Ai zheng = Aizheng = Chinese journal of cancer.

[Phase II clinical study of intratumoral H101, an E1B deleted adenovirus, in combination with chemotherapy in patients with cancer].

Yang Zhang, Zhongyu Yuan, Z. Guan, 2003, Ai zheng = Aizheng = Chinese journal of cancer.

Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial

Y. Ba, Jianming Xu, Jun Liang, 2011, Chinese journal of cancer.

Efficacy and safety of bevacizumab in metastatic colorectal cancer: pooled analysis from seven randomized controlled trials.

J. Tabernero, F. Kabbinavar, H. Hurwitz, 2013, The oncologist.

Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy

Yang Zhang, Z. Guan, Pei-yu Huang, 2007, Cancer Chemotherapy and Pharmacology.

Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin’s lymphoma cells

Wen-Qi Jiang, Jun-min Zhou, Xiao-Feng Zhu, 2008, Cancer biology & therapy.

Intensive chemotherapy improved treatment outcome for Chinese children and adolescents with lymphoblastic lymphoma

Z. Guan, Hui-Qiang Huang, Z. Xia, 2008, International Journal of Clinical Oncology.

Capecitabine/cisplatin versus 5‐fluorouracil/cisplatin in Chinese patients with advanced and metastatic gastric cancer: Re‐analysis of efficacy and safety data from the ML17032 phase III clinical trial

Leizhen Zheng, Z. Guan, Jie-jun Wang, 2018, Asia-Pacific journal of clinical oncology.

A Pilot Study of Oxaliplatin, Fluorouracil and Folinic Acid (FOLFOX-6) as First-Line Chemotherapy in Advanced or Recurrent Gastric Cancer

Li Zhang, Yu-hong Li, Tongyu Lin, 2008, Chemotherapy.

[A study on the long-term non-small cell lung cancer survivors in the Expand Access Program of gefitinib in China].

B. Han, Jianming Xu, Yilong Wu, 2012, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning

Wen-Qi Jiang, Xiao-shi Zhang, Z. Guan, 2007, BMC Cancer.

Randomized phase III trial of sorafenib versus placebo in patients with advanced hepatocellular carcinoma (HCC)

Yoon-Koo Kang, Jun Suk Kim, A. Cheng, 2007 .

A phase II study of gemcitabine plus paclitaxel in patients with metastatic breast cancer and prior anthracycline treatment

Bing-he Xu, Zefei Jiang, Z. Guan, 2010, Asia-Pacific journal of clinical oncology.

Superior efficacy of a Cremophor‐free albumin‐bound paclitaxel compared with solvent‐based paclitaxel in Chinese patients with metastatic breast cancer

Shiying Yu, Zefei Jiang, Z. Guan, 2009 .

Safety and efficacy of first-line bevacizumab combination therapy in Chinese population with advanced non-squamous NSCLC: data of subgroup analyses from MO19390 (SAiL) study

C. Bai, Yi-long Wu, G. Jiang, 2013, Clinical and Translational Oncology.

Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results.

Wen-Qi Jiang, Z. Guan, He Huang, 2013, International journal of clinical pharmacology and therapeutics.

Inhibition of DNA primase and induction of apoptosis by 3,3'-diethyl-9-methylthia-carbocyanine iodide in hepatocellular carcinoma BEL-7402 cells.

Wen-Qi Jiang, Jun-min Zhou, G. Feng, 2004, World journal of gastroenterology.

Efficacy, Tolerability, and Biomarker Analyses of Once‐Every‐2‐Weeks Cetuximab Plus First‐Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild‐Type Metastatic Colorectal Cancer: The Phase 2 APEC Study

P. Gibbs, D. Doval, T. Yau, 2017, Clinical colorectal cancer.

A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel.

Ying Cheng, Yi-long Wu, B. Han, 2018, Translational lung cancer research.

[Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients].

Qinghua Zhou, Yiping Zhang, Z. Guan, 2005, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[Phase III randomized clinical trial of intratumoral injection of E1B gene-deleted adenovirus (H101) combined with cisplatin-based chemotherapy in treating squamous cell cancer of head and neck or esophagus].

Yang Zhang, Wen-Qi Jiang, Li Zhang, 2004, Ai zheng = Aizheng = Chinese journal of cancer.

Pharmacokinetic characteristics and anticancer effects of 5-Fluorouracil loaded nanoparticles

Z. Guan, Wenqi Jiang, Anxun Wang, 2008, BMC Cancer.

[Multivariate survival analysis for 423 patients with non-small cell lung cancer].

Wen-Qi Jiang, Li Zhang, Z. Guan, 2003, Ai zheng = Aizheng = Chinese journal of cancer.

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.

Yoon-Koo Kang, Jianming Xu, S. Ye, 2009, The Lancet. Oncology.

Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma

Wen-Qi Jiang, Huiyan Luo, Z. Guan, 2008, BMC Cancer.

Clinical analysis of primary systemic anaplastic large cell lymphoma: a report of 57 cases.

J. Zeng, Fenghua Wang, Wen-Qi Jiang, 2009, Ai zheng = Aizheng = Chinese journal of cancer.

[Trastuzumab in combination with chemotherapy versus chemotherapy alone for first-line treatment of HER2-positive advanced gastric or gastroesophageal junction cancer: a Phase III, multi-center, randomized controlled trial, Chinese subreport].

Jianming Xu, L. Shen, M. Tao, 2013, Zhonghua zhong liu za zhi [Chinese journal of oncology].

The preliminary results of treatment ofadvanced and recurrent malignant lymphoma by beac regimen supported with autologous hematopoietic stem cells transplantation

Wen-Qi Jiang, Li Zhang, Tongyu Lin, 2002 .

A tolerability study of a cremophor free, nanoparticle albumin bound paclitaxel intravenously administered in Chinese patients with advanced solid tumor

P. Soon-Shiong, Z. Guan, M. Hawkins, 2005 .

[Primary breast lymphoma--a report of 27 cases with literature review].

Tongyu Lin, Z. Guan, You-jian He, 2007, Ai zheng = Aizheng = Chinese journal of cancer.

Platinums sensitize human epithelial tumor cells to lymphotoxin α by inhibiting NF-κB-dependent transcription

Qing Xu, Z. Wang, Z. Guan, 2008 .

High incidence of hepatitis B virus infection in B‐cell subtype non‐Hodgkin lymphoma compared with other cancers

Wen-Qi Jiang, Tongyu Lin, Huiyan Luo, 2007, Cancer.

Randomized study comparing nab-paclitaxel with solvent-based paclitaxel in Chinese patients (pts) with metastatic breast cancer (MBC)

Z. Guan, Z. Jiang, M. Hawkins, 2007 .

Randomized controlled comparative clinical pharmacokinetic study of nab-paclitaxel and solvent-based paclitaxel in Chinese patients (pts) with metastatic breast cancer (MBC)

Z. Guan, X. Teng, M. Hawkins, 2007 .

[Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].

Z. Guan, Z. Xia, Qiu-liang Wu, 2005, Zhonghua bing li xue za zhi = Chinese journal of pathology.

Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma

Wen-Qi Jiang, Li Zhang, Yu-hong Li, 2006, Cancer.

[Extrapulmonary small cell carcinoma in 52 patients].

Zhongyu Yuan, Z. Guan, Yi Xia, 2006, Ai zheng = Aizheng = Chinese journal of cancer.

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

Yoon-Koo Kang, M. Lichinitser, Z. Guan, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors

R. Xu, Z. Guan, S. Li, 2009, Cancer Gene Therapy.

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma

Fenghua Wang, Wen-Qi Jiang, Li Zhang, 2008, Annals of Hematology.

Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone

Bing-he Xu, M. Desilvio, Zefei Jiang, 2014, Breast Cancer Research.

Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.

H. Gómez, Bing-he Xu, M. Desilvio, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacokinetics and tolerability of vandetanib in Chinese patients with solid, malignant tumors: an open-label, phase I, rising multiple-dose study.

Z. Guan, Su Li, H. Liao, 2011, Clinical therapeutics.

Multicenter randomized phase 2 clinical trial of a recombinant human endostatin adenovirus in patients with advanced head and neck carcinoma.

Wenlin Huang, T. Kang, Jiang-xue Wu, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumors

J. Shao, M. Zeng, Z. Guan, 2008, Gene Therapy.

[Safety of an E1B deleted adenovirus administered intratumorally to patients with cancer].

Li Zhang, Zhongyu Yuan, Z. Guan, 2003, Ai zheng = Aizheng = Chinese journal of cancer.

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trial.

Yoon-Koo Kang, Jianming Xu, Jun Suk Kim, 2012, European journal of cancer.

A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel

Ying Cheng, Yi-long Wu, B. Han, 2017, ESMO Open.

The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase iii randomized trials

Qing Liu, Z. Guan, Chong Zhao, 2010, BMC Cancer.

[Primary central nervous system lymphoma--a report of 32 cases with literature review].

Ying Guo, Y. Xia, Z. Guan, 2006, Ai zheng = Aizheng = Chinese journal of cancer.

Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B‐non‐Hodgkin's lymphoma‐Berlin‐Frankfurt‐Münster‐90 protocol

Z. Guan, You-jian He, Yi Xia, 2006, European journal of haematology.

[Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer].

Jian-hua Chang, Z. Guan, Ning Li, 2005, Ai zheng = Aizheng = Chinese journal of cancer.

Efficacy and Safety Of Pegaspargase With Gemcitabine and Oxaliplatin In Patients With Treatment-naïve, Refractory Extranodal Natural Killer/T-Cell Lymphoma: A Single-Centre Experience

Wei Zhao, Z. Guan, Wenqi Jiang, 2013 .

High Ki‐67 expression in diffuse large B‐cell lymphoma patients with non‐germinal center subtype indicates limited survival benefit from R‐CHOP therapy

Wen-Qi Jiang, Wei Zhao, Z. Guan, 2012, European journal of haematology.

Preliminary outcome of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin’s lymphoma: single institution experience

Fenghua Wang, Z. Guan, Wenqi Jiang, 2006 .

[Treatment of lymphoma patients with fludarabine-based regimens: a report of 29 cases].

Wen-Qi Jiang, Yu-hong Li, Z. Guan, 2004, Ai zheng = Aizheng = Chinese journal of cancer.

[Relationship between tumor necrosis factor genetic polymorphisms and acute lymphocytic leukemia].

Wen-Qi Jiang, Z. Guan, X. Zhong, 2003, Ai zheng = Aizheng = Chinese journal of cancer.

A multicenter phase II study of the efficacy and safety of docetaxel plus cisplatin in Asian chemonaïve patients with metastatic or locally advanced non-small cell lung cancer.

E. Tan, Z. Guan, M. Liao, 2003, Respiratory medicine.

Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer: findings from the ATHENA study.

Ying Cheng, Bing-he Xu, Z. Guan, 2012, Chinese Medical Journal.

Clinical characteristics and prognostic factors in Chinese patients with Hodgkin’s lymphoma

Wen-Qi Jiang, Z. Guan, Zhiming Li, 2012, Medical Oncology.

Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma

Z. Chen, M. Lehnert, Z. Guan, 2003, British Journal of Cancer.

A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancers

Yang Zhang, Shaojie Wang, Z. Guan, 2014, Archives of medical science : AMS.

[Significance of EGFR and p-ERK expression in nasopharyngeal carcinoma].

Wen-Qi Jiang, Li Zhang, Z. Guan, 2006, Zhonghua zhong liu za zhi [Chinese journal of oncology].

A phase III study of S-1 plus cisplatin versus fluorouracil plus cisplatin in patients with advanced gastric or gastroesophageal junction adenocarcinoma.

Ying Cheng, Jianming Xu, He-long Zhang, 2013 .

[CD4+CD25+T regulatory cells in peripheral blood of B-NHL patients with or without chemotherapy].

Wen-Qi Jiang, Xiao-shi Zhang, Z. Guan, 2004, Ai zheng = Aizheng = Chinese journal of cancer.

[Efficacy of rituximab-containing regimens on indolent B-cell lymphoma--a report of 34 cases].

Fenghua Wang, Wen-Qi Jiang, Yu-hong Li, 2006, Ai zheng = Aizheng = Chinese journal of cancer.

Chemotherapy for nasopharyngeal carcinoma

Z. Guan, Guan Zhong-zhen, 2004 .

[Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen].

Wen-Qi Jiang, Yu-hong Li, Z. Guan, 2004, Ai zheng = Aizheng = Chinese journal of cancer.

Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial.

Y. Ba, Shiying Yu, Z. Guan, 2011, Chinese journal of cancer.

Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP

Wen-Qi Jiang, P. Sun, Z. Guan, 2015, Annals of Hematology.

5050 POSTER Lapatinib (L) in Combination With Paclitaxel (P) is an Effective and Tolerable Treatment in HER2-overexpressing Metastatic Breast Cancer (MBC) Patients

Bing-he Xu, M. Desilvio, B. Newstat, 2011 .

[Preliminary result of multi-center clinical trial on the docetaxel, 5-Fu and DDP in the treatment of advanced, recurrent or metastatic nasopharyngeal carcinoma].

Yu-hong Li, Z. Guan, Y. Shuang, 2008, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].

Wen-Qi Jiang, Yu-hong Li, Z. Guan, 2004, Ai zheng = Aizheng = Chinese journal of cancer.

Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.

H. Gómez, Bing-he Xu, M. Desilvio, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results.

Wen-Qi Jiang, Z. Guan, He Huang, 2013, International journal of clinical pharmacology and therapeutics.

A Pilot Study of Oxaliplatin, Fluorouracil and Folinic Acid (FOLFOX-6) as First-Line Chemotherapy in Advanced or Recurrent Gastric Cancer

Li Zhang, Yu-hong Li, B. Han, 2008, Chemotherapy.

[A tolerability study of A cremophor-free albumin bound nanoparticle paclitaxel intravenously administered in patients with advanced solid tumor].

P. Soon-Shiong, Z. Guan, M. Hawkins, 2004, Ai zheng = Aizheng = Chinese journal of cancer.

High Ki‐67 expression in diffuse large B‐cell lymphoma patients with non‐germinal center subtype indicates limited survival benefit from R‐CHOP therapy

Wen-Qi Jiang, Wei Zhao, Z. Guan, 2012, European journal of haematology.

[Nadaplatin or cisplatin combined with paclitaxol in treatment for non-small cell lung cancer: a randomized controlled study].

Z. Guan, Guang-chuan Xu, Li-kun Chen, 2007, Zhonghua zhong liu za zhi [Chinese journal of oncology].

Final safety and efficacy data for Asian patients (pts) in the MO19390 (SAiL) trial: First-line bevacizumab (Bv) plus chemotherapy in advanced or recurrent non-small cell lung cancer (NSCLC).

Yi-long Wu, G. Jiang, Z. Guan, 2010 .

Pharmacokinetic characteristics and anticancer effects of 5-Fluorouracil loaded nanoparticles

Z. Guan, Wenqi Jiang, Su Li, 2008, BMC Cancer.